Increase in Antidepressant Medication in the US Adult Population between 1990 and 2003
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Background: The rate of antidepressant treatment in the US has significantly increased in the past decade. There are, however, concerns about undertreatment among traditionally underserved groups and overtreatment in less severely ill individuals. This study examines trends in the prevalence of antidepressant drug treatment in two US general population surveys. Methods: The prevalence of antidepressant treatment within a 12-month period was compared in the US National Comorbidity Survey (1990–1992) and the National Comorbidity Survey-Replication (2001–2003). Variations in trends across groups were examined using bivariate and multivariate logistic regression models. Results: The rate of antidepressant drug treatment increased more than four times between early 1990s and early 2000s. The trend was similar across sociodemographic groups. Younger adults, men and racial/ethnic minorities continued to receive antidepressant treatment at a lower rate compared to middle-aged adults, women and non-Hispanic whites, respectively. The rate of antidepressant treatment increased more in the group of less severely ill individuals than in those with more severe psychopathology. Conclusions: Sociodemographic disparities in antidepressant treatment persisted over the last decade in the US, lending support to concerns about undertreatment among traditionally underserved groups, whereas the greater increase in the rate of antidepressant treatment in the less severely ill group lends support to concerns about antidepressant overtreatment in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These changes in attitudes were matched by significant increases in the use of mental health services in recent years (20-25).”
From Attitudes toward mental health help seeking as predictors of future help-seeking behavior and use of mental health treatments (2016) · cites this paper as [22]
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
KESSLER, R. C., ANDREWS, G., COLPE, L. J., HIRIPI, E., MROCZEK, D. K., NORMAND, S.-L. T., WALTERS, E. E., & ZASLAVSKY, A. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006074 · Cited by 10,327 · cited 1×
“The items covered depressed mood, loss of interest, hopelessness, trouble concentrating, inappropriate guilt or feelings of worthlessness, lack of energy, worrying too much, feeling tense, feeling ‘trapped’, and feeling lonely. The respondents were asked to rate the frequency of each symptom over the past 30 days on a…”
MethodInfluentialKessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Screening for serious mental illness in the general population
Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., Howes, M. J., Normand, S.-L. T., Manderscheid, R. W., Walters, E. E., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.184 · Cited by 5,692
Mental Health: A Report of the Surgeon General
(1999) · PsycEXTRA Dataset · doi:10.1037/e636982009-001 · Cited by 3,097
Wittchen, H.-U. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90036-1 · Cited by 2,348
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910 · cited 1×
“corresponding to the following definitions of impairment: (1) lost days: the number of days in which the respondent was ‘totally unable to work or carry out normal activities’, (2) cutback days: the number of days in which the respondent had to ‘cut down’ on what he/she did or ‘did not get as much done as usual’, and…”
BackgroundKessler, R. C. (2005) · JAMA · doi:10.1001/jama.293.20.2487 · Cited by 1,073 · cited 1×
“Suicidality was assessed by presenting the participants with a list of different experiences including thinking seriously about suicide, making a plan for committing suicide and attempting suicide. Reports of any of these experiences in the past 12 months were rated as a positive rating of suicidality. Previous report…”
MethodAnderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940 · cited 1×
“However, consistency of results across different measures of psychopathology and impairment of role functioning lends support to the results based on diagnosis. Second, common mood and anxiety disorders tend to have a recurrent course and continued antidepressant treatment in patients with these conditions is often in…”
ResultThe Hopkins Symptom Checklist (HSCL)
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000395070 · Cited by 894
National Trends in the Outpatient Treatment of Depression
Olfson, M. (2002) · JAMA · doi:10.1001/jama.287.2.203 · Cited by 847
The National Comorbidity Survey Replication (NCS‐R): background and aims
Kessler, R. C., & Merikangas, K. R. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.166 · Cited by 723 · cited 1×
“conducted between 1990 and 1992, and the National Comorbidity Survey-Replication (NCS-R) [”
MethodThe impact of psychiatric disorders on work loss days
KESSLER, R. C., & FRANK, R. G. (1997) · Psychological Medicine · doi:10.1017/s0033291797004807 · Cited by 716 · cited 1×
“disorders (major depression, dysthymia, GAD, PTSD, panic disorder with or without agoraphobia, social anxiety) as ascertained by the CIDI (odds ratio, OR = 15.47, 95p confidence interval, CI = 9.42–25.42, t = 11.13, p”
MethodInfluentialKravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L., & Franks, P. (2005) · JAMA · doi:10.1001/jama.293.16.1995 · Cited by 586 · cited 1×
“and aggressive pharmaceutical marketing strategies such as direct to consumer advertising of pharmaceuticals in the US [”
BackgroundKrämer, P. (1993) · Medical Entomology and Zoology · Cited by 578
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.11.1351 · Cited by 367
Changing Profiles of Service Sectors Used for Mental Health Care in the United States
Wang, P. S., Demler, O., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1187 · Cited by 364 · cited 1×
“p. 618] notes, The pattern of spread of treatments to people with less serious conditions is not unique to mental health. New medical technologies invariably diffuse beyond the population for whom they were originally designed ... Diffusion of new technologies typically occurs without regard to need, resulting in a mi…”
BackgroundAssociation between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis
Hall, W. D. (2003) · BMJ · doi:10.1136/bmj.326.7397.1008 · Cited by 310
Racial Variation in Antidepressant Treatment in a Medicaid Population
Melfi, C. A., Croghan, T. W., Hanna, M. P., & Robinson, R. L. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0105 · Cited by 228
Better but not well: mental health policy in the United States since 1950
(2007) · Choice Reviews Online · doi:10.5860/choice.44-4478 · Cited by 191
Barbui, C., & Hotopf, M. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.129 · Cited by 182
Marked Differences in Antidepressant Use by Race in an Elderly Community Sample: 1986–1996
Blazer, D. G., Hybels, C. F., Simonsick, E. M., & Hanlon, J. T. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1089 · Cited by 160 · cited 1×
“There are also concerns about the enduring sociodemographic disparities in access to antidepressant medications [”
Background(2000) · Cited by 128
Trends in service use and treatment for mental disorders in adults throughout Great Britain
Brugha, T. S., Bebbington, P. E., Singleton, N., Melzer, D., Jenkins, R., Lewis, G., Farrell, M., Bhugra, D., Lee, A., & Meltzer, H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.5.378 · Cited by 114
Antidepressant utilization in Canada
Beck, C. A., Patten, S. B., Williams, J. V. A., Wang, J., Currie, S. R., Maxwell, C. J., & el‐Guebaly, N. (2005) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-005-0968-0 · Cited by 108 · cited 1×
“The rate of antidepressant treatment in the US and other industrialized countries has significantly increased since late 1980s [”
BackgroundOxman, T. E., & Sengupta, A. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200205000-00004 · Cited by 90
The Intellectual Crisis of Psychiatric Research
Fava, G. A. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000092890 · Cited by 79 · cited 1×
“increased preference of care providers for pharmacological treatments instead of psychotherapeutic interventions [”
BackgroundPerlis, R. H., Beasley Jr., C. M., Wines Jr., J. D., Tamura, R. N., Cusin, C., Shear, D., Amsterdam, J., Quitkin, F., Strong, R. E., Rosenbaum, J. F., et al. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000096363 · Cited by 78
The prognosis of minor depression in the general population: a systematic review
Hermens, M. L., van Hout, H. P. J., Terluin, B., van der Windt, D., Beekman, A. T. F., van Dyck, R., & de Haan, M. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2004.08.006 · Cited by 77 · cited 1×
“Furthermore, many of these mild conditions may be self-limiting and resolve spontaneously [”
BackgroundDo Antidepressant and Antianxiety Drugs Increase Chronicity in Affective Disorders?
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288880 · Cited by 73
Increased Recognition of Depression in Primary Care
Berardi, D., Menchetti, M., Cevenini, N., Scaini, S., Versari, M., & de Ronchi, D. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000085146 · Cited by 71
Long-Term Treatment with Antidepressant Drugs: The Spectacular Achievements of Propaganda
Fava, G. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000056279 · Cited by 66
Residual Symptoms and Impairment in Major Depression in the Community
Mojtabai, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1645 · Cited by 65
Self-citation(2005) · Choice Reviews Online · doi:10.5860/choice.42-4682 · Cited by 49
Newsom, J. T., Prigerson, H. G., Schulz, R., & Reynolds, C. F. (2003) · The International Journal of Aging and Human Development · doi:10.2190/13lv-b3mm-pewj-3p3w · Cited by 37 · cited 1×
“Data Analysis Association of sociodemographic and clinical characteristics with antidepressant medication treatment was assessed using binary logistic regressions. For multi-category variables, the statistical significance of the association was tested using Wald tests.Variations in trends in antidepressant treatment…”
MethodTreatment for Depression Following the 1996 National Depression Screening Day
Greenfield, S. F., Reizes, J. M., Muenz, L. R., Kopans, B., Kozloff, R. C., & Jacobs, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1867 · Cited by 37 · cited 1×
“Several developments in recent years likely contributed to this trend including increased demand for treatment of depression motivated by public education and screening campaigns focused on common mental health problems [”
BackgroundThe Controversy Of Increased Spending For Antidepressants
Croghan, T. W. (2001) · Health Affairs · doi:10.1377/hlthaff.20.2.129 · Cited by 33 · cited 1×
“Furthermore, introduction of new antidepressants has increased the supply of these medications. Fluoxetine received Food and Drug Administration approval for treatment of major depression in 1987, followed shortly by sertraline (1991), paroxetine (1992), venlafaxine (1993), mirtazapine (1996), citalopram (1998) and, m…”
BackgroundRising Mental Health Costs: What Are We Getting For Our Money?
Druss, B. G. (2006) · Health Affairs · doi:10.1377/hlthaff.25.3.614 · Cited by 32
Sherbourne, C. D., Weiss, R., Duan, N., Bird, C. E., & Wells, K. B. (2004) · Medical Care · doi:10.1097/00005650-200412000-00005 · Cited by 25
Faravelli, C., Cosci, F., Ciampelli, M., Scarpato, M. A., Spiti, R., & Ricca, V. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068689 · Cited by 22 · cited 1×
“and they may even be less effective than older medications in real world settings [”
BackgroundDatapoints: Prescription Patterns for Mood and Anxiety Disorders in a Community Population
Mojtabai, R. (1999) · Psychiatric Services · doi:10.1176/ps.50.12.1557 · Cited by 9
Self-citation
Research works printed but not linked: 2
- 10.1176%2Fappi.ajgp.10.3.256 · doi:10.1176/appi.ajgp.10.3.256
- 10.1176%2Fappi.ajp.163.7.1187 · doi:10.1176/appi.ajp.163.7.1187 · Paper page
Cited by
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
Jorm, A. F., Patten, S. B., Brugha, T. S., & Mojtabai, R. (2017) · World Psychiatry · doi:10.1002/wps.20388 · Cited by 556
Self-citationNational Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry
Mojtabai, R., & Olfson, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.175 · Cited by 479
Self-citationNational trends in the treatment for depression from 1998 to 2007
Marcus, S. C., & Olfson, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.151 · Cited by 312
Metadata
- Authors
- Mojtabai, R.
- Affiliations
- Mount Sinai Beth Israel (US)
- Corresponding author
- Mojtabai, Ramin
- ORCID
- Mojtabai, Ramin
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 77
- Issue
- 2
- Pages
- 83-92
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2093923613
- Cited by
- 100
- References
- 44
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 9 · 2013: 8 · 2012: 6
- FWCI
- 15.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, sociodemographic disparities, underserved populations, depression, psychopathology severity, National Comorbidity Survey, National Comorbidity Survey Replication, racial and ethnic minorities, gender differences, age differences
- MeSH terms
- Adolescent, Adult, Antidepressive Agents, Cross-Sectional Studies, Depressive Disorder, Major, Major Depressive Disorder, Drug Therapy, Drug Utilization, Female, Humans, Male, Middle Aged, Population Surveillance, Socioeconomic Factors, United States, Incidence, Selective Serotonin Reuptake Inhibitors, Health Care Surveys
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.